$CERS
CERUS CORP Stock $cers

$cers Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000119312514303221 Filed on August 08, 2014

Income Statement

Concept	2014 Q2	2013 Q2
Revenue	$8.601M	$10.15M
YoY Change	-15.26%	10.04%
Cost Of Revenue	$4.752M	$5.747M
YoY Change	-17.31%	3.1%
Gross Profit	$3.849M	$4.403M
YoY Change	-12.58%	20.63%
Gross Profit Margin	44.75%	43.38%
Selling, General & Admin	$10.08M	$7.954M
YoY Change	26.73%	18.97%
% of Gross Profit	261.89%	180.65%
Research & Development	$4.722M	$3.506M
YoY Change	34.68%	104.79%
% of Gross Profit	122.68%	79.63%
Depreciation & Amortization	$290.0K	$110.0K
YoY Change	163.64%	-42.11%
% of Gross Profit	7.53%	2.5%
Operating Expenses	$14.85M	$11.51M
YoY Change	29.03%	36.24%
Operating Profit	-$11.00M	-$7.108M
YoY Change	54.81%	48.11%
Interest Expense	$34.00K	$107.0K
YoY Change	-68.22%	-20.74%
% of Operating Profit
Other Income/Expense, Net	$3.459M	$438.0K
YoY Change	689.73%	-85.07%
Pretax Income	-$7.545M	-$6.670M
YoY Change	13.12%	257.45%
Income Tax	$44.00K	$54.00K
% Of Pretax Income
Net Earnings	-$7.589M	-$6.724M
YoY Change	12.86%	252.6%
Net Earnings / Revenue	-88.23%	-66.25%
Basic Earnings Per Share	-$0.10	-$0.10
Diluted Earnings Per Share	-$0.16	-$0.10
COMMON SHARES
Basic Shares Outstanding	72.90M shares	69.73M shares
Diluted Shares Outstanding	74.52M shares	71.93M shares

Balance Sheet

Concept	2014 Q2	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$49.70M	$58.20M
YoY Change	-14.6%	117.98%
Cash & Equivalents	$28.56M	$58.20M
Short-Term Investments	$21.10M
Other Short-Term Assets	$1.416M	$200.0K
YoY Change	608.0%	-80.0%
Inventory	$13.38M	$12.76M
Prepaid Expenses	$1.353M	$739.0K
Receivables	$4.478M	$5.868M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$70.32M	$77.77M
YoY Change	-9.58%	90.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.615M	$1.641M
YoY Change	120.29%	-13.63%
Goodwill	$1.316M	$1.316M
YoY Change	0.0%
Intangibles	$1.243M	$1.445M
YoY Change	-13.98%
Long-Term Investments
YoY Change
Other Assets	$51.00K	$72.00K
YoY Change	-29.17%	-82.0%
Total Long-Term Assets	$6.532M	$4.778M
YoY Change	36.71%	-9.85%
TOTAL ASSETS
Total Short-Term Assets	$70.32M	$77.77M
Total Long-Term Assets	$6.532M	$4.778M
Total Assets	$76.85M	$82.55M
YoY Change	-6.9%	79.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.169M	$5.035M
YoY Change	-37.06%	43.86%
Accrued Expenses	$10.62M	$8.748M
YoY Change	21.39%	32.55%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$2.200M
YoY Change	-100.0%	-40.54%
Total Short-Term Liabilities	$21.71M	$26.38M
YoY Change	-17.72%	16.22%
LONG-TERM LIABILITIES
Long-Term Debt	$9.800M	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$987.0K	$1.145M
YoY Change	-13.8%	-4.58%
Total Long-Term Liabilities	$987.0K	$1.145M
YoY Change	-13.8%	-76.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.71M	$26.38M
Total Long-Term Liabilities	$987.0K	$1.145M
Total Liabilities	$32.64M	$27.60M
YoY Change	18.26%	0.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$511.0M	-$476.8M
YoY Change	7.17%
Common Stock	$74.00K	$70.00K
YoY Change	5.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$44.21M	$54.95M
YoY Change
Total Liabilities & Shareholders Equity	$76.85M	$82.55M
YoY Change	-6.9%	79.06%

Cashflow Statement

Concept	2014 Q2	2013 Q2
OPERATING ACTIVITIES
Net Income	-$7.589M	-$6.724M
YoY Change	12.86%	252.6%
Depreciation, Depletion And Amortization	$290.0K	$110.0K
YoY Change	163.64%	-42.11%
Cash From Operating Activities	-$9.610M	-$5.690M
YoY Change	68.89%	5.57%
INVESTING ACTIVITIES
Capital Expenditures	-$590.0K	-$150.0K
YoY Change	293.33%	150.0%
Acquisitions
YoY Change
Other Investing Activities	$2.970M	-$10.00K
YoY Change	-29800.0%	-111.11%
Cash From Investing Activities	$2.380M	-$160.0K
YoY Change	-1587.5%	-633.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	11.81M	-5.110M
YoY Change	-331.12%	-996.49%
NET CHANGE
Cash From Operating Activities	-9.610M	-5.690M
Cash From Investing Activities	2.380M	-160.0K
Cash From Financing Activities	11.81M	-5.110M
Net Change In Cash	4.580M	-10.96M
YoY Change	-141.79%	128.81%
FREE CASH FLOW
Cash From Operating Activities	-$9.610M	-$5.690M
Capital Expenditures	-$590.0K	-$150.0K
Free Cash Flow	-$9.020M	-$5.540M
YoY Change	62.82%	3.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	74048000	shares
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58201000
CY2013Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0
CY2014Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	17700000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.07
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12018000	shares
CY2014Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	3227000
CY2014Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2014Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	9848000
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	21707000
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	6000
CY2014Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2440000
CY2014Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1324000
CY2014Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	555131000
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3169000
CY2014Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2773000
CY2014Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7653000
CY2014Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	987000
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	44208000
CY2014Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7653000
CY2014Q2	us-gaap	Secured Debt Current SecuredDebtCurrent	0
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-511003000
CY2014Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	266000
CY2014Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	2314000
CY2014Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10619000
CY2014Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	3227000
CY2014Q2	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	7653000
CY2014Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	3227000
CY2014Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	695000
CY2014Q2	us-gaap	Long Term Debt LongTermDebt	12980000
CY2014Q2	us-gaap	Liabilities Liabilities	32644000
CY2014Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	290000
CY2014Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	774000
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	74000
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	76852000
CY2014Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	102000
CY2014Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	100000
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51000
CY2014Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	21134000
CY2014Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1353000
CY2014Q2	us-gaap	Goodwill Goodwill	1316000
CY2014Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	27457000
CY2014Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	27457000
CY2014Q2	us-gaap	Cost Method Investments CostMethodInvestments	0
CY2014Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	307000
CY2014Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1243000
CY2014Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4478000
CY2014Q2	us-gaap	Inventory Net InventoryNet	13377000
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	200000
CY2014Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10686000
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	200000
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	100000
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3615000
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28562000
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	200000
CY2014Q2	us-gaap	Assets Assets	76852000
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	545905000
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5674000
CY2013Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2722000
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	20390000
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1073000
CY2014Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1200000
CY2014Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1243000
CY2014Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1416000
CY2014Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2691000
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	200000
CY2014Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	27463000
CY2014Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	27463000
CY2014Q2	us-gaap	Inventory Finished Goods And Work In Process Net Of Reserves InventoryFinishedGoodsAndWorkInProcessNetOfReserves	13377000
CY2014Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2017000
CY2014Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	27463000
CY2014Q2	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	27457000
CY2014Q2	us-gaap	Assets Current AssetsCurrent	70320000
CY2014Q2	cers	Debt Instrument Carrying Current DebtInstrumentCarryingCurrent	0
CY2014Q2	cers	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	200000
CY2014Q2	cers	Debt Instrument Carrying Non Current DebtInstrumentCarryingNonCurrent	10000000
CY2014Q2	cers	Available For Sale Securities Debt Maturities After One Through Three Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost	0
CY2014Q2	cers	Leasehold Improvement Reflected In Other Non Current Liabilities LeaseholdImprovementReflectedInOtherNonCurrentLiabilities	600000
CY2014Q2	cers	Debt Instrument Unamortized Current DebtInstrumentUnamortizedCurrent	0
CY2014Q2	cers	Accrued Inventory AccruedInventory	4082000
CY2014Q2	cers	Leasehold Improvement Reflected In Accrued Liabilities LeaseholdImprovementReflectedInAccruedLiabilities	100000
CY2014Q2	cers	Outstanding Liability Related To Leasehold Improvements Current And Non Current OutstandingLiabilityRelatedToLeaseholdImprovementsCurrentAndNonCurrent	700000
CY2014Q2	cers	Cumulative Outstanding Trade Receivables Number Of Major Customers CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers	3	Customer
CY2014Q2	cers	Debt Instrument Unamortized Noncurrent DebtInstrumentUnamortizedNoncurrent	152000
CY2014Q2	cers	Available For Sale Securities Debt Maturities After One Through Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue	0
CY2014Q2	cers	Finite Lived Intangible Assets Amortization Expense Year Seven FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven	100000
CY2014Q2	cers	Available For Sale Securities Gross Unrealized Gain Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainLossAccumulatedInInvestments	6000
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26696000
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.46
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10405000	shares
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	0
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	39424000
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	7000
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2527000
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1011000
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	42795000
CY2013Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	20390000
CY2013Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	3366000
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-503189000
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	181000
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9813000
CY2013Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	20390000
CY2013Q4	us-gaap	Liabilities Liabilities	40586000
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	673000
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	72000
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	83381000
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	89000
CY2013Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	400000
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	70000
CY2013Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	28191000
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	848000
CY2013Q4	us-gaap	Goodwill Goodwill	1316000
CY2013Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	36834000
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	30700000
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	308000
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1344000
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6125000
CY2013Q4	us-gaap	Inventory Net InventoryNet	13063000
CY2013Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8200000
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2189000
CY2013Q4	us-gaap	Assets Assets	83381000
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29485000
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1344000
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	442000
CY2013Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4863000
CY2013Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	36841000
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	36841000
CY2013Q4	us-gaap	Inventory Finished Goods And Work In Process Net Of Reserves InventoryFinishedGoodsAndWorkInProcessNetOfReserves	13063000
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2017000
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	30701000
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	36834000
CY2013Q4	us-gaap	Assets Current AssetsCurrent	78154000
CY2013Q4	cers	Debt Instrument Carrying Current DebtInstrumentCarryingCurrent	3366000
CY2013Q4	cers	Debt Instrument Carrying Non Current DebtInstrumentCarryingNonCurrent	0
CY2013Q4	cers	Available For Sale Securities Debt Maturities After One Through Three Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost	6134000
CY2013Q4	cers	Debt Instrument Unamortized Current DebtInstrumentUnamortizedCurrent	0
CY2013Q4	cers	Accrued Inventory AccruedInventory	3553000
CY2013Q4	cers	Cumulative Outstanding Trade Receivables Number Of Major Customers CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers	2	Customer
CY2013Q4	cers	Debt Instrument Unamortized Noncurrent DebtInstrumentUnamortizedNoncurrent	0
CY2013Q4	cers	Available For Sale Securities Debt Maturities After One Through Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue	6140000
CY2013Q4	cers	Available For Sale Securities Gross Unrealized Gain Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainLossAccumulatedInInvestments	7000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64756000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-14041000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16123000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64756000	shares
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-492000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	13000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	19883000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	33000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-16976000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-16871000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1424000
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-211000
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	6149000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16976000
	us-gaap	Gross Profit GrossProfit	9046000
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12068000
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	180000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-56000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4803000
	us-gaap	Net Income Loss NetIncomeLoss	-16976000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1341000
	us-gaap	Dilutive Securities DilutiveSecurities	0
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	10837000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	45739000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	13000
	us-gaap	Share Based Compensation ShareBasedCompensation	1554000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	31505000
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-193000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0
	us-gaap	Operating Expenses OperatingExpenses	21114000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14807000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	105000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	76000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	990000
	us-gaap	Interest Expense InterestExpense	238000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2151000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	51171000
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	6206000
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	526000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	283000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	101000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1554000
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	191000
	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	-4387000
	cers	Payment For Royalty PaymentForRoyalty	1600000
	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	7600000
	dei	Trading Symbol TradingSymbol	CERS
	dei	Entity Registrant Name EntityRegistrantName	CERUS CORP
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2014-06-30
	dei	Entity Central Index Key EntityCentralIndexKey	0001020214
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.53
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	9.78
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	30000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74927000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2432000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.00
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-19436000
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	900000	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Concentration of Credit Risk</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, short-term investments and accounts receivable.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Pursuant to the Company’s investment policy, substantially all of the Company’s cash, cash equivalents and short-term investments are maintained at a major financial institution of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company’s investments carry high credit quality ratings, which is in accordance with its investment policy. At June 30, 2014, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company’s cash equivalents.</p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px">  </p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"> Concentrations of credit risk with respect to trade receivables exist. However, for certain customers, the Company purchases a credit insurance policy that mitigates some of its credit risk, as the policy will pay either the Company or its lender on eligible claims filed on its outstanding receivables. On a regular basis, including at the time of sale, the Company performs credit evaluations of its customers. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company reserves against the accounts receivable on its condensed consolidated balance sheets and records a charge on its condensed consolidated statements of operations. At June 30, 2014 and December 31, 2013, the Company had not recorded any reserves for potentially uncollectible accounts.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The Company had three customers and two customers that accounted for more than 10% of the Company’s outstanding trade receivables at each of June 30, 2014 and December 31, 2013, respectively. These customers cumulatively represented approximately 65% and 55% of the Company’s outstanding trade receivables, at June 30, 2014 and December 31, 2013, respectively. To date, the Company has not experienced collection difficulties from these customers.</p> </div>
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	98000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11587000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.49
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2641000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72495000	shares
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	Segment
	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, which are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p> </div>
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Guarantee and Indemnification Arrangements</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company after December 31, 2002. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company’s technology infringes the intellectual property rights of a third party or claims that the sale or use of the Company’s products have caused personal injury or other damage or loss. The Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The Company generally provides for a one-year warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims become known and are estimable.</p> </div>
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-12525000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	450000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	3492000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	16467000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	304000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-20855000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7732000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1647000
	us-gaap	Goodwill Other Changes GoodwillOtherChanges	0
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4000
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	3419000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7815000
	us-gaap	Gross Profit GrossProfit	7558000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20223000
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	3800000
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	1429000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	0
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12491000
	us-gaap	Net Income Loss NetIncomeLoss	-7814000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1411000
	us-gaap	Dilutive Securities DilutiveSecurities	-13041000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	8909000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	13135000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	13000
	us-gaap	Share Based Compensation ShareBasedCompensation	2286000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-923000
	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	3000000
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	5378000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	10299000
	us-gaap	Operating Expenses OperatingExpenses	27781000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18316000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	82000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	85000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	743000
	us-gaap	Interest Expense InterestExpense	334000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2625000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3847000
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	9364000
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	9848000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	615000
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	101000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2286000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	212000
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2859000
	cers	Safety Product Warranty Period SafetyProductWarrantyPeriod	P1Y
	cers	Prior Written Notice Period For Termination Of Agreement PriorWrittenNoticePeriodForTerminationOfAgreement	P24M
	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	12525000
	cers	Minimum Term Of Non Cancelable Operating Leases MinimumTermOfNonCancelableOperatingLeases	P1Y
	cers	Payment For Royalty PaymentForRoyalty	1300000
	cers	Expiration Of Non Cancelable Operating Leases Maximum Year ExpirationOfNonCancelableOperatingLeasesMaximumYear	2019
	cers	Inventory Life Finished Goods Period InventoryLifeFinishedGoodsPeriod	P2Y
	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	9500000
CY2013Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10633000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69727000	shares
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6724000
CY2013Q2	us-gaap	Gross Profit GrossProfit	4403000
	cers	Work In Process Inventory Life Period WorkInProcessInventoryLifePeriod	P1Y
	cers	Eligible To Receive Royalty Fee EligibleToReceiveRoyaltyFee	0.01	pure
	cers	Agreement Expiration Date AgreementExpirationDate	2014-09-30
	cers	Sales Commissions And Fees Per Unit SalesCommissionsAndFeesPerUnit	10
CY2010	cers	Proceeds From Landlord Financing Leasehold Improvement ProceedsFromLandlordFinancingLeaseholdImprovement	1100000
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71928000	shares
CY2013Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2201000	shares
CY2013Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	10150000
CY2013Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16000
CY2013Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-7410000
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6670000
CY2013Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-157000
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-7108000
CY2013Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	438000
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-6724000
CY2013Q2	us-gaap	Dilutive Securities DilutiveSecurities	-686000
CY2013Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	5747000
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	11511000
CY2013Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7954000
CY2014Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10080000
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44000
CY2014Q2	us-gaap	Interest Expense InterestExpense	141000
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	54000
CY2013Q2	us-gaap	Interest Expense InterestExpense	107000
CY2013Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	3506000
CY2013Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51000
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	841000
CY2013Q2	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2013Q2	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	686000
CY2013Q2	cers	Payment For Royalty PaymentForRoyalty	700000
CY2013Q2	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	3600000
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74517000	shares
CY2014Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1618000	shares
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12160000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72899000	shares
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1000
CY2014Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	8601000
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	134000
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11596000
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7545000
CY2014Q2	us-gaap	Goodwill Other Changes GoodwillOtherChanges	0
CY2014Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-25000
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7590000
CY2014Q2	us-gaap	Gross Profit GrossProfit	3849000
CY2014Q2	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-11004000
CY2014Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	1100000
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3459000
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-7589000
CY2014Q2	us-gaap	Dilutive Securities DilutiveSecurities	-4007000
CY2014Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2014Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4752000
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	14853000
CY2014Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	4722000
CY2014Q2	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0
CY2014Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51000
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1341000
CY2014Q2	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2014Q2	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2014Q2	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	3491000
CY2014Q2	cers	Payment For Royalty PaymentForRoyalty	600000
CY2014Q2	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	4900000

Files In Submission

Name	View Source	Status
0001193125-14-303221-index-headers.html	Edgar Link	pending
0001193125-14-303221-index.html	Edgar Link	pending
0001193125-14-303221.txt	Edgar Link	pending
0001193125-14-303221-xbrl.zip	Edgar Link	pending
cers-20140630.xml	Edgar Link	completed
cers-20140630.xsd	Edgar Link	pending
cers-20140630_cal.xml	Edgar Link	unprocessable
cers-20140630_def.xml	Edgar Link	unprocessable
cers-20140630_lab.xml	Edgar Link	unprocessable
cers-20140630_pre.xml	Edgar Link	unprocessable
d748617d10q.htm	Edgar Link	pending
d748617dex101.htm	Edgar Link	pending
d748617dex102.htm	Edgar Link	pending
d748617dex311.htm	Edgar Link	pending
d748617dex312.htm	Edgar Link	pending
d748617dex321.htm	Edgar Link	pending
d748617dex33.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CERS
CERUS CORP Stock $cers

2014 Q2 Form 10-Q Financial Statement

#000119312514303221 Filed on August 08, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CERS CERUS CORP Stock $cers

2014 Q2 Form 10-Q Financial Statement

#000119312514303221 Filed on August 08, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CERS
CERUS CORP Stock $cers